Robust antibody and cellular responses induced by DNA-only vaccination for HIV.

Saved in:
Bibliographic Details
Title: Robust antibody and cellular responses induced by DNA-only vaccination for HIV.
Authors: De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA., Edupuganti S; Division of Infectious Disease, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA., Han X; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Elizaga M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Swann E; Division of AIDS, NIH, Bethesda, Maryland, USA., Polakowski L; Division of AIDS, NIH, Bethesda, Maryland, USA., Kalams SA; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Keefer MC; Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York, USA., Maenza J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA., Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Wise MC; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA., Yan J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA., Morrow MP; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA., Khan AS; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA., Boyer JD; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA., Humeau L; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA., White S; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA., Pensiero M; Division of AIDS, NIH, Bethesda, Maryland, USA., Sardesai NY; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA., Bagarazzi ML; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania, USA., Weiner DB; Wistar Institute, Philadelphia, Pennsylvania, USA., Ferrari G; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Tomaras GD; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
Corporate Authors: HIV Vaccine Trials Network (HVTN) 098 Study Team
Source: JCI insight [JCI Insight] 2020 Jul 09; Vol. 5 (13). Date of Electronic Publication: 2020 Jul 09.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first